Suchergebnisse

The present paper describes policies and guidelines for scholarly publishing of biodiversity and biodiversity-related data, elaborated and updated during the Framework Program 7 EU BON project, on the basis of an earlier version published on Pensoft's website in 2011. The document discusses some general concepts, including a definition of datasets, incentives to publish data and licenses for data publishing. Further, it defines and compares several routes for data publishing, namely as (1) supplementary files to research articles, which may be made available directly by the publisher, or (2) published in a specialized open data repository with a link to it from the research article, or (3) as a data paper, i.e., a specific, stand-alone publication describing a particular dataset or a collection of datasets, or (4) integrated narrative and data publishing through online import/download of data into/from manuscripts, as provided by the Biodiversity Data Journal. The paper also contains detailed instructions on how to prepare and peer review data intended for publication, listed under the Guidelines for Authors and Reviewers, respectively. Special attention is given to existing standards, protocols and tools to facilitate data publishing, such as the Integrated Publishing Toolkit of the Global Biodiversity Information Facility (GBIF IPT) and the DarwinCore Archive (DwC-A). A separate section describes most leading data hosting/indexing infrastructures and repositories for biodiversity and ecological data.

A group of publishers came together to discuss how we could reduce the complexity and inconsistency provided in publisher's advice to researchers when selecting an appropriate data repository. It is a shared goal among publishers and other stakeholders to increase repository use – which remains far from optimal – and we assume that helping researchers find a suitable repository more easily will help achieve this. To address this a list of features has been created and it is intended only as a framework within which publishers can make recommendations to researchers, not as a way to restrict which repositories researchers may choose for their data. Our intention is that the features we highlight will act to initiate engagement and collaboration among publishers, repositories and the RPOs, government and funders that ultimately make the policies around Open Research. As we start this conversation, it is important that we act together with other stakeholders to raise awareness of the challenges involved around FAIR data and to prevent any perverse consequences. From the RDA FAIRsharing WG point of view, the ultimate objective is to map repository features across all existing initiatives, and to identify a common core set of metadata fields that all stakeholders want to see in registry of repositories. The FAIRsharing registry in particular is agnostic as to the selection process of standards, repositories and policies, as part of its commitment to working with and for all stakeholder groups.

© The Author(s), 2012. This article is distributed under the terms of the Creative Commons Attribution License. The definitive version was published in Nature Genetics 44 (2012): 121-126, doi:10.1038/ng.1054. ; To make full use of research data, the bioscience community needs to adopt technologies and reward mechanisms that support interoperability and promote the growth of an open 'data commoning' culture. Here we describe the prerequisites for data commoning and present an established and growing ecosystem of solutions using the shared 'Investigation-Study-Assay' framework to support that vision. ; The authors also acknowledge the following funding sources in particular: UK Biotechnology and Biological Sciences Research Council (BBSRC) BB/I000771/1 to S.-A.S. and A.T.; UK BBSRC BB/I025840/1 to S.-A.S.; UK BBSRC BB/I000917/1 to D.F.; EU CarcinoGENOMICS (PL037712) to J.K.; US National Institutes of Health (NIH) 1RC2CA148222-01 to W.H. and the HSCI; US MIRADA LTERS DEB-0717390 and Alfred P. Sloan Foundation (ICoMM) to L.A.-Z.; Swiss Federal Government through the Federal Office of Education and Science (FOES) to L.B. and I.X.; EU Innovative Medicines Initiative (IMI) Open PHACTS 115191 to C.T.E.; US Department of Energy (DOE) DE-AC02- 06CH11357 and Arthur P. Sloan Foundation (2011- 6-05) to J.G.; UK BBSRC SysMO-DB2 BB/I004637/1 and BBG0102181 to C.G.; UK BBSRC BB/I000933/1 to C.S. and J.L.G.; UK MRC UD99999906 to J.L.G.; US NIH R21 MH087336 (National Institute of Mental Health) and R00 GM079953 (National Institute of General Medical Science) to A.L.; NIH U54 HG006097 to J.C. and C.E.S.; Australian government through the National Collaborative Research Infrastructure Strategy (NCRIS); BIRN U24-RR025736 and BioScholar RO1-GM083871 to G.B. and the 2009 Super Science initiative to C.A.S.